Event-Free Survival and intravascular ultrasound (IVUS) measures 1.5 years [clinicaltrials_resource:fc9e06098c3a0327b6f57844e2d8aa60]

Event-Free Survival (EFS) is a composite of: the development of hemodynamic compromise with rejection, allograft dysfunction (hemodynamic compromise without histologically confirmed rejection), death from any cause, or re-transplantation. IVUS co-primary endpoint: maximal intimal thickness of the coronary arteries from baseline (measured at 6 weeks ± 30 days) to month 12 of ≥0.5mm, as measured by IVUS.

Event-Free Survival and intravascular ultrasound (IVUS) measures 1.5 years [clinicaltrials_resource:fc9e06098c3a0327b6f57844e2d8aa60]

Event-Free Survival (EFS) is a composite of: the development of hemodynamic compromise with rejection, allograft dysfunction (hemodynamic compromise without histologically confirmed rejection), death from any cause, or re-transplantation. IVUS co-primary endpoint: maximal intimal thickness of the coronary arteries from baseline (measured at 6 weeks ± 30 days) to month 12 of ≥0.5mm, as measured by IVUS.